Theophylline and Antipyrine Disposition in Smoking and Non-smoking Epileptic Subjects
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Theophylline and antipyrine disposition has been compared in smoking epileptic patients, non-smoking epileptic patients and non-smoking healthy volunteers. Although clear differences in drug clearance and half-life were evident as a result of anticonvulsant drug therapy, no effect of smoking was discernible. Thus, additive effects from induction of the hepatic microsomal monooxygenase system in man by anticonvulsant drugs and polycyclic aromatic hydrocarbons (in cigarette smoke) were not evident.
Citing Articles
Rutishauser S, Ali A, Jeffrey I, Hunt L, Braganza J Int J Pancreatol. 1995; 18(2):117-26.
PMID: 8530827 DOI: 10.1007/BF02785885.
References
1.
Sladek N, MANNERING G
. Induction of drug metabolism. II. Qualitative differences in the microsomal N-demethylating systems stimulated by polycyclic hydrocarbons and by phenobarbital. Mol Pharmacol. 1969; 5(2):186-99.
View
2.
Vestal R, Norris A, Tobin J, Cohen B, SHOCK N, Andres R
. Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking. Clin Pharmacol Ther. 1975; 18(4):425-32.
DOI: 10.1002/cpt1975184425.
View
3.
Lu A, West S
. Multiplicity of mammalian microsomal cytochromes P-45. Pharmacol Rev. 1979; 31(4):277-95.
View
4.
Park B, Breckenridge A
. Clinical implications of enzyme induction and enzyme inhibition. Clin Pharmacokinet. 1981; 6(1):1-24.
DOI: 10.2165/00003088-198106010-00001.
View
5.
Grygiel J, Birkett D
. Cigarette smoking and theophylline clearance and metabolism. Clin Pharmacol Ther. 1981; 30(4):491-6.
DOI: 10.1038/clpt.1981.193.
View